 MENLO PARK, Calif. and BOSTON, Oct. 12, 2021 GLOBE NEWSWIRE -- Adicet Bio, Inc. Nasdaq: ACET, a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, today announced Blake Aftab, Ph.D., has been promoted to the position of Senior Vice President and Chief Scientific Officer. In this role, Dr. Aftab will be responsible for the continued expansion of Adicets pipeline of therapeutic candidates in solid and hematologic tumors. 